MetLife (MET) Trading at 25% Due to 'Regulator Overhang'; More Upside Seen

Goldman Sachs today maintained a Buy rating on MetLife (NYSE: MET) with a price target of $45.00. This morning MetLife shares moved higher after it announced a nearly 50 percent dividend increase to $0.275 per quarter from $0.185, its first increase since 2007.

Commenting on the news, analyst Christopher Giovanni said, "We estimate there is a 25%+ regulatory overhang discount for MET and Prudential Financial (NYSE: PRU). We believe this overhang will decline as greater clarity on non-bank SIFI emerges and indications of greater shareholder value (consistent with MET's dividend increase) begin to accelerate, driving multiple expansion."

For an analyst ratings summary and ratings history on MetLife (NYSE: MET) click here. For more ratings news on MetLife click here.

Shares of MetLife closed at $35.79 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Mizuho Reiterates Outperform Rating on Broadcom Limited (AVGO) Into EPS
• DA Davidson Starts Comfort Systems USA (FIX) at Buy
• Benchmark Reiterates Buy Rating on Rank One Computing (ROC)